ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

NCI’s Justification For 1981 Budget

June 8, 1979

IOM Report Lists Cancer CER Priorities

July 3, 2009

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991

Clinical Education Guidelines Proposed

April 4, 1975

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002